Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen dose-ranging trial for alcohol dependence
ACTRN12606000100594Phase 3Not yet recruiting
- Sponsor
- Sydney South West Area Health Service
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of baclofen in alcohol dependence (3 arms), sponsored by Sydney South West Area Health Service. Primary endpoints: Reduction in proportion of heavy drinking days, Side-effect burden and 1 more. Planned start May 2006; status: not yet recruiting.
02
Drugs
baclofen
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on ACTRN12606000100594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000100594.